Answers are grounded in this paper and cite their sources.
V ulvar lichen sclerosus (VLS) is an underserved area in medicine and dermatology. We discuss updates in VLS, which include the following: (1) development of core outcome domains to include in all future clinical trials, with current efforts focused on determining outcome measurements for each domain; (2) increased understanding of the impact VLS has on quality-of-life (QOL) outcomes; (3) expanded disease associations; (4) clinical and histologic variants, including vestibular sclerosis and nonsclerotic VLS; and (5) updates in management of VLS.
No takes yet. Share an insight, caveat, or question.
Britney Nguyen (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: